Pharma & Biotech

A dramatic reassessment is underway for Intellia Therapeutics, sending shockwaves through the biotech investment community. Market research firm Morningstar has...

Shares of medical technology firm SI-Bone have surged approximately 55% over the past year, nearly touching their 52-week high of...

A dramatic strategic shift appears to be paying off for Novavax, as the biotech firm moves away from a high-risk...

Biopharmaceutical firm Ocugen approaches a potentially transformative event as it prepares to present at the NobleCon21 conference on December 3,...

As US markets remain closed for the Thanksgiving holiday, shares of Viking Therapeutics are enjoying a brief respite. The stock...

The European biotech landscape is poised for a significant transformation as BioNTech approaches the final stages of its planned acquisition...

Investors in Danish pharmaceutical giant Novo Nordisk experienced a rollercoaster week, marked by a significant clinical setback swiftly followed by...

A dramatic financial confrontation is unfolding around Replimune Group, where hedge funds betting against the company face off against institutional...

Investors in Novo Nordisk witnessed a dramatic reversal this week as the pharmaceutical giant's stock surged, breaking a persistent downward...

The landscape of mRNA technology is undergoing a significant transformation. BioNTech, the Mainz-based biotech firm renowned for its COVID-19 vaccine,...